Cargando…
Cell-based therapy technology classifications and translational challenges
Cell therapies offer the promise of treating and altering the course of diseases which cannot be addressed adequately by existing pharmaceuticals. Cell therapies are a diverse group across cell types and therapeutic indications and have been an active area of research for many years but are now stro...
Autores principales: | Mount, Natalie M., Ward, Stephen J., Kefalas, Panos, Hyllner, Johan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4634004/ https://www.ncbi.nlm.nih.gov/pubmed/26416686 http://dx.doi.org/10.1098/rstb.2015.0017 |
Ejemplares similares
-
Data collection infrastructure for patient outcomes in the UK – opportunities and challenges for cell and gene therapies launching
por: Jørgensen, Jesper, et al.
Publicado: (2019) -
Outcomes-based reimbursement for gene therapies in practice: the experience of recently launched CAR-T cell therapies in major European countries
por: Jørgensen, Jesper, et al.
Publicado: (2020) -
Reimbursement of licensed cell and gene therapies across the major European healthcare markets
por: Jørgensen, Jesper, et al.
Publicado: (2015) -
Annuity payments can increase patient access to innovative cell and gene therapies under England’s net budget impact test
por: Jørgensen, Jesper, et al.
Publicado: (2017) -
Market access pathways for cell therapies in France
por: Rémuzat, Cécile, et al.
Publicado: (2015)